These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27433309)

  • 1. H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
    Kutz C
    Ther Adv Chronic Dis; 2016 Jul; 7(4):190-7. PubMed ID: 27433309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).
    Gold LS; Suh K; Schepman PB; Damal K; Hansen RN
    Adv Ther; 2016 Aug; 33(8):1279-92. PubMed ID: 27312977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis.
    Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ
    Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.
    Kaplan J; Miller T; Baker M; Due B; Zhao E
    Front Neurol; 2020; 11():598496. PubMed ID: 33414758
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
    Murray S; Woo A
    Ther Adv Neurol Disord; 2016 May; 9(3):189-97. PubMed ID: 27134674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population.
    Nazareth T; Datar M; Yu TC
    Neurol Ther; 2019 Dec; 8(2):383-395. PubMed ID: 31564036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acthar
    Kaplan J; Askanase A; Chu D; Abdellatif A; Basu D; Mirsaeidi M
    Clin Drug Investig; 2023 Oct; 43(10):739-761. PubMed ID: 37792273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
    Philbin M; Niewoehner J; Wan GJ
    Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse.
    Kaplan J; Miller T; Baker M; Due B; Zhao E
    Neurodegener Dis Manag; 2021 Dec; 11(6):469-476. PubMed ID: 34860120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
    Wynn D; Goldstick L; Bauer W; Zhao E; Tarau E; Cohen JA; Robertson D; Miller A
    CNS Neurosci Ther; 2022 Mar; 28(3):364-371. PubMed ID: 34984839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.
    Li X; Golubovsky J; Hui-Yuen J; Shah U; Olech E; Lomeo R; Singh V; Busch H; Strandberg MJ; Strandberg K; Horowitz L; Askanase A
    F1000Res; 2015; 4():1103. PubMed ID: 27158444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®).
    Gold LS; Schepman PB; Wang WJ; Philbin M; Niewoehner J; Damal K; Hansen RN
    Adv Ther; 2016 Aug; 33(8):1293-304. PubMed ID: 27324137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.
    Rice JB; Panaccio MP; White A; Simes M; Billmyer E; Downes N; Niewoehner J; Wan GJ
    Neurol Ther; 2021 Jun; 10(1):149-167. PubMed ID: 33170434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006921. PubMed ID: 23235634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis.
    Hunter SF; Bindra J; Chopra I; Niewoehner J; Panaccio MP; Wan GJ
    Clinicoecon Outcomes Res; 2021; 13():883-892. PubMed ID: 34675568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus.
    Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio M; Wan GJ
    Adv Ther; 2023 Jan; 40(1):194-210. PubMed ID: 36266383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropic hormone analog use for podocytopathies.
    Filippone EJ; Dopson SJ; Rivers DM; Monk RD; Udani SM; Jafari G; Huang SC; Melhem A; Assioun B; Schmitz PG
    Int Med Case Rep J; 2016; 9():125-33. PubMed ID: 27418857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.
    Wan GJ; Niewoehner J; Hayes K
    Clinicoecon Outcomes Res; 2023; 15():499-512. PubMed ID: 37397803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.